Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Normative Hand Grip Strength Values in Swedish Male and Female Ice Hockey Players Across Competitive Levels

22. mai 2026 oppdatert av: Daniel Muder, Dalarna County Council, Sweden

This study measures hand grip strength in male and female ice hockey players across different Swedish leagues to create reference (normative) values for adult players.

Hand grip strength is a simple test of how strongly a person can squeeze with their hand. Although it seems basic, it reflects overall upper-body strength and is widely used in both sports science and healthcare.

In this project, players from different levels of ice hockey (including professional men's and women's leagues, junior players, and recreational players if available) will have their grip strength measured using a standardized hand dynamometer. Measurements will be taken in a consistent way across all participating clubs.

The main goal is to build a reference database showing what "normal" grip strength looks like in ice hockey players depending on sex, league level, and playing position. This can help coaches, medical staff, and researchers better understand strength profiles in hockey athletes, support training and rehabilitation decisions, and provide benchmarks for future studies.

No treatment or intervention is given as part of the study.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

This is a cross-sectional, descriptive, multi-league study designed to establish normative values for maximal isometric hand grip strength in adult Swedish ice hockey players.

Hand grip strength will be used as a standardized, low-cost proxy measure of upper-body muscular strength and general functional capacity. Although grip strength is widely used in clinical and sports science settings and has demonstrated good reliability when measured using standardized protocols, there is currently a lack of comprehensive normative data for adult ice hockey players. Existing literature is largely limited to youth cohorts or general athletic "combine"-type populations, with insufficient stratification for adult competitive ice hockey across sexes, league levels, and playing positions.

This study will include male and female players from multiple competitive levels in Swedish ice hockey, including professional leagues (SHL and SDHL), second-tier leagues (HockeyAllsvenskan and Women's Allsvenskan where feasible), junior elite levels (U18/U20), and potentially recreational adult players. Participants will be recruited through participating clubs during the pre-season or early competitive season period.

Grip strength will be measured using a standardized hand dynamometer according to a unified protocol aligned with established clinical measurement guidelines (including standardized positioning, device calibration, and repeated trials per hand). Both dominant and non-dominant hand grip strength will be recorded, and mean values will be used for analysis. To reduce inter-tester variability, participating sites will be instructed to follow a harmonized measurement protocol.

In addition to grip strength, basic demographic and anthropometric data will be collected, including age, sex, playing position (forward/defense), playing experience, height, and body mass. Where available, supplementary body composition data from club testing routines may also be included to allow exploratory analyses of strength relative to body size.

The primary purpose of the study is descriptive: to generate normative reference values (including percentiles) for grip strength in adult ice hockey players, stratified by sex, league level, and playing position. Secondary analyses will explore associations between grip strength and anthropometric and demographic variables.

This study does not include any intervention or experimental treatment. All measurements are non-invasive and performed during routine testing environments within clubs. The results are intended to support strength and conditioning practice, clinical assessment in sports medicine, and future research on performance, injury risk, and rehabilitation in ice hockey.

Studietype

Observasjonsmessig

Registrering (Antatt)

800

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Adult male and female ice hockey players recruited from Swedish ice hockey clubs across multiple competitive levels, including professional (SHL and SDHL), second-tier (HockeyAllsvenskan and Women's Allsvenskan where available), junior elite (U18/U20), and selected recreational teams. Participants are drawn from active club rosters during the pre-season or early competitive season period. Recruitment is conducted in collaboration with participating clubs and their medical or strength and conditioning staff. The population represents a broad sample of Swedish ice hockey players across sex, age, and competitive level.

Beskrivelse

Inclusion Criteria:

  • Adult male or female ice hockey players.
  • Registered and actively participating in a Swedish ice hockey club during the current season.
  • Participation in one of the included competitive levels: professional, semi-professional, junior elite, or recreational leagues in Sweden.
  • Able to perform maximal hand grip strength testing. Provides written informed consent.

Exclusion Criteria:

  • Current acute injury of the upper extremity (hand, wrist, forearm, or elbow) that prevents safe or valid grip strength testing.
  • Any medical condition that contraindicates maximal effort testing, as determined by team medical staff or study personnel.
  • Refusal or inability to provide informed consent.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Ice Hockey Players
Adult male and female ice hockey players from multiple competitive levels in Sweden, including professional, semi-professional, junior elite, and recreational players. Participants undergo a single standardized measurement of hand grip strength.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Maximal Hand Grip Strength
Tidsramme: Baseline.
Maximal isometric hand grip strength measured in kilograms using a standardized hand dynamometer in adult male and female ice hockey players. Measurements will be performed for both dominant and non-dominant hands using a standardized protocol, and mean maximal value will be used for analysis.
Baseline.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Anthropometric Characteristics
Tidsramme: Baseline.
Height (cm), body mass (kg), and body composition (if available) of adult male and female ice hockey players.
Baseline.
Demographic and Playing Characteristics
Tidsramme: Baseline.
Age, sex, playing position (forward/defense), league level, dominant hand, and years of playing experience in ice hockey.
Baseline.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Daniel Muder, MD, PhD, Centre for Clinical Research Dalarna, Uppsala University, Sweden

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. september 2026

Primær fullføring (Antatt)

31. desember 2026

Studiet fullført (Antatt)

31. desember 2026

Datoer for studieregistrering

Først innsendt

23. april 2026

Først innsendt som oppfylte QC-kriteriene

30. april 2026

Først lagt ut (Faktiske)

5. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

27. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

22. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2026-02210-01B

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Any data shared with colleagues or collaborating researchers will be fully anonymized or pseudonymized to protect participant privacy in accordance with GDPR regulations. Data transfers will occur under strict confidentiality agreements, and all parties will adhere to applicable data protection laws to ensure the security and privacy of personal information. We will act in accordance with the ethical approval granted by the Swedish Ethical Review Authority (EPM) and comply with all relevant local policies regarding data protection.

IPD-delingstidsramme

From the publication of the protocol and for 10 years thereafter.

Tilgangskriterier for IPD-deling

Access to individual participant data is typically restricted to authorized researchers involved in the study or approved collaborators under strict confidentiality and data protection agreements.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • ICF

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere